AAF
Andra AP-fonden’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,279,900
| Closed | -$11.3M | – | 600 |
|
|
2023
Q1 | $11.3M | Buy |
1,279,900
+519,700
| +68% | +$4.6M | 0.29% | 66 |
|
|
2022
Q4 | $6.93M | Buy |
760,200
+376,100
| +98% | +$3.43M | 0.21% | 189 |
|
|
2022
Q3 | $3.1M | Sell |
384,100
-155,600
| -29% | -$1.26M | 0.1% | 404 |
|
|
2022
Q2 | $4.06M | Buy |
+539,700
| New | +$4.06M | 0.12% | 393 |
|
|
2021
Q4 | $7.78M | Buy |
970,900
+552,200
| +132% | +$4.42M | 0.16% | 306 |
|
|
2021
Q3 | $4.08M | Sell |
418,700
-254,500
| -38% | -$2.48M | 0.08% | 475 |
|
|
2021
Q2 | $6.67M | Sell |
673,200
-15,700
| -2% | -$155K | 0.14% | 365 |
|
|
2021
Q1 | $7.95M | Buy |
688,900
+50,700
| +8% | +$585K | 0.18% | 266 |
|
|
2020
Q4 | $6.16M | Buy |
638,200
+372,600
| +140% | +$3.6M | 0.14% | 375 |
|
|
2020
Q3 | $2.39M | Sell |
265,600
-243,500
| -48% | -$2.19M | 0.06% | 547 |
|
|
2020
Q2 | $6.28M | Buy |
509,100
+87,800
| +21% | +$1.08M | 0.18% | 210 |
|
|
2020
Q1 | $3.78M | Sell |
421,300
-59,900
| -12% | -$538K | 0.14% | 383 |
|
|
2019
Q4 | $4.72M | Buy |
481,200
+100,200
| +26% | +$982K | 0.13% | 417 |
|
|
2019
Q3 | $2.62M | Sell |
381,000
-206,900
| -35% | -$1.42M | 0.08% | 568 |
|
|
2019
Q2 | $5.43M | Buy |
587,900
+189,300
| +47% | +$1.75M | 0.16% | 321 |
|
|
2019
Q1 | $6.25M | Buy |
+398,600
| New | +$6.25M | 0.18% | 219 |
|
|
2018
Q3 | $7.74M | Buy |
359,200
+213,700
| +147% | +$4.6M | 0.2% | 176 |
|
|
2018
Q2 | $3.54M | Sell |
145,500
-99,700
| -41% | -$2.43M | 0.1% | 515 |
|
|
2018
Q1 | $4.19M | Buy |
245,200
+172,200
| +236% | +$2.94M | 0.11% | 491 |
|
|
2017
Q4 | $1.38M | Buy |
73,000
+60,900
| +503% | +$1.15M | 0.03% | 626 |
|
|
2017
Q3 | $213K | Sell |
12,100
-4,700
| -28% | -$82.7K | 0.01% | 660 |
|
|
2017
Q2 | $558K | Sell |
16,800
-72,300
| -81% | -$2.4M | 0.01% | 654 |
|
|
2017
Q1 | $2.86K | Sell |
89,100
-12,600
| -12% | -$404 | 0.07% | 417 |
|
|
2016
Q4 | $3.69M | Buy |
+101,700
| New | +$3.69M | 0.1% | 328 |
|